颅内血肿微创清除术的临床应用  

The Clinical Application of Micro-Debridement about Intracranial Hematoma

作　　者：谭宝麟[1] 廖建平[1] 李敏英[1] 

机构地区：[1]广东省四会市人民医院神经外科,526200

出　　处：《中国医药指南》2009年第1期8-9,共2页Guide of China Medicine

摘　　要：目的通过微创技术的临床应用,提高各种原因所致颅内出血引起的颅内血肿的救治率,减少颅内血肿后遗症的发生。方法全组156例,依CT检查定位,采用YL-1型穿剌针穿刺置入血肿腔,并配合尿激酶和肝素等血肿液化技术,反复冲洗引流,清除颅内血肿。结果156例患者出院时按GOS评定,痊愈102例(65.4%),中残19例(12.2%),重残5例(3.2%),植物生存4例(2.6%),死亡12例(7.7%),本组良好率为77.6%,病死率为7.7%。结论微创颅内血肿清除术是一种简单、安全、有效的治疗方法,可作为治疗颅内血肿首选治疗方法在基层医院广泛开展应用。Objective Through the clinical application of micro-technical, to increase the remedy rate of intracranial hematoma caused by any reasons, reduce intracranial hematoma sequelae. Methods Total 156 patients, by CT examination, and use YL-1 type puncture needle pricking haematoma cavity, combination haematoma fluidify technology about urokinase and beparin etc, wash dnge repeatedly, to clean intracranial hematoma. Result Total 156 patients to evaluate by GOS to leave hospital, 102 eases is recovery（65.4%）, 19 cases is moderate disability（12.2%）, 5 cases is severe disability（3.2%）, 4 cases is plant man（2.6%）, 12 cases is death（7.7%）, and rate of prognosis well is 77.6%, case fatality is 7.7%. Conclusion Micro-debridement about intracranial hematoma is a simple, safe, and effective treatment method. It may be a first treatment method to treat intracranial hematoma in primary level hospital.

关 键 词：颅内血肿微创清除术 临床应用 颅内血肿 

分 类 号：R651.15[医药卫生—外科学]